B-Myb represses vascular smooth muscle cell collagen gene expression and inhibits neointima formation after arterial injury

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 9, 2004, Pages 1608-1613

  Hofmann, Claudia S ^a   Sullivan, Christopher P ^a   Jiang, Hao Yuan ^a   Stone, Phillip J ^a   Toselli, Paul ^a   Reis, Ernane D ^b   Chereshnev, Igor ^b   Schreiber, Barbara M ^a   Sonenshein, Gail E ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aorta; Collagen; Cyclin A; Femoral artery; Myb

Indexed keywords

B MYB PROTEIN; COLLAGEN; COLLAGEN TYPE 1; CYCLIN A; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; AORTA; ARTERY INJURY; ARTERY INTIMA; ARTERY INTIMA PROLIFERATION; ARTERY WALL; ARTICLE; CYTOMEGALOVIRUS; FEMORAL ARTERY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MOUSE; NONHUMAN; ONCOGENE MYB; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; AORTA; CELL CYCLE PROTEINS; COLLAGEN; CYCLIN A; CYTOMEGALOVIRUS; DNA-BINDING PROTEINS; FEMALE; FEMORAL ARTERY; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANS-ACTIVATORS; TRANSGENES; TUNICA INTIMA;

EID: 4444295918     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000139010.71779.f3     Document Type: Article

References (38)

1. Ross R, Klebanoff SJ. The smooth muscle cell. I. In vivo synthesis of connective tissue proteins. J Cell Biol. 1971;50:159-171.
2. Murata K, Motayama T, Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 1986;60:251-262.
3. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 1994;75:650-658.
4. Rekhter MD. Collagen synthesis in atherosclerosis: too much and not enough. Cardiovasc Res. 1999;41:376-384.
5. Libby P, Tanaka H. The molecular bases of restenosis. Prog Cardiovasc Dis. 1997;40:97-106.
6. Wilensky RL, March KL, Gradus-Pizlo I, Sandusky G, Fineberg N, Hathaway DR. Vascular injury, repair, and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Circulation. 1995;92:2995-3005.
7. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK. A cascade model for restenosis. A special case of atherosclerosis progression. Circulation. 1992;86:III47-III52.
8. Beldekas JC, Gerstenfeld L, Sonenshein GE, Franzblau C. Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J Biol Chem. 1982;257:12252-12256.
9. Stepp MA, Kindy MS, Franzblau C, Sonenshein GE. Complex regulation of collagen gene expression in cultured bovine aortic smooth muscle cells. J Biol Chem. 1986;261:6542-6547.
10. Liau G, Chan LM. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J Biol Chem. 1989;264:10315-10320.
11. Kypreos KE, Nugent MA, Sonenshein GE. Basic fibroblast growth factor-induced decrease in type I collagen gene transcription is mediated by B-myb. Cell Growth Differ. 1998;9:723-730.
12. Marhamati DJ, Sonenshein GE. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J Biol Chem. 1996;271:3359-3365.
13. Mizuguchi G, Nakagoshi H, Nagase T, Nomura N, Date T, Ueno Y, Ishii S. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB. J Biol Chem. 1990;265:9280-9284.
14. Johnson LR, Johnson TK, Desler M, Luster TA, Nowling T, Lewis RE, Rizzino A. Effects of B-Myb on gene transcription: phosphorylation-dependent activity and acetylation by p300. J Biol Chem. 2002;277:4088-4097.
15. Lam EW, Bennett JD, Watson RJ. Cell-cycle regulation of human B-myb transcription. Gene. 1995;160:277-281.
16. Foos G, Grimm S, Klempnauer KH. Functional antagonism between members of the myb family: B-myb inhibits v-myb-induced gene activation. EMBO J. 1992;11:4619-4629.
17. Tashiro S, Takemoto Y, Handa H, Ishii S. Cell type-specific transactivation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain. Oncogene. 1995;10:1699-1707.
18. Kypreos KE, Marhamati DJ, Sonenshein GE. B-Myb represses transactivation of the Col5A2 collagen promoter indirectly via inhibition of binding of factors interacting with positive elements within the first exon. Matrix Biol. 1999;18:275-285.
19. Masselink H, Vastenhouw N, Bernards R. B-myb rescues ras-induced premature senescence, which requires its transactivation domain. Cancer Lett. 2001;171:87-101.
20. Petrovas C, Jeay S, Lewis RE, Sonenshein GE. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain. Oncogene. 2003;22:2011-2020.
21. Luchetti MM, Paroncini P, Majlingova P, Frampton J, Mucenski M, Baroni SS, Sambo P, Golay J, Introna M, Gabrielli A. Characterization of the c-Myb-responsive region and regulation of the human type I collagen α 2 chain gene by c-Myb. J Biol Chem. 2003;278:1533-1541.
22. Cicchillitti L, Jimenez SA, Sala A, Saitta B. B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts. Biochem J. 2004;378:609-616.
23. Baskar JF, Smith PP, Nilaver G, Jupp RA, Hoffmann S, Peffer NJ, Tenney DJ, Colberg-Poley AM, Ghazal P, Nelson JA. The enhancer domain of the human cytomegalovirus major immediate-early promoter determines cell type-specific expression in transgenic mice. J Virol. 1996;70:3207-3214.
24. Myers JC, Dickson LA, de Wet WJ, Bernard MP, Chu ML, Di Liberto M, Pepe G, Sangiorgi FO, Ramirez F. Analysis of the 3′ end of the human pro-α 2(I) collagen gene. Utilization of multiple polyadenylation sites in cultured fibroblasts. J Biol Chem. 1983;258:10128-10135.
25. Quaglino D, Fornieri C, Nanney LB, Davidson JM. Extracellular matrix modifications in rat tissues of different ages. Correlations between elastin and collagen type I mRNA expression and lysyl-oxidase activity. Matrix. 1993;13:481-490.
26. Hata R. Age-dependent changes in collagen metabolism and response to hypertonic culture conditions of rat aortic smooth muscle cells and skin fibroblasts. Cell Biol Int Rep. 1990;14:25-33.
27. Olivetti G, Anversa P, Melissari M, Loud AV. Morphometric study of early postnatal development of the thoracic aorta in the rat. Circ Res. 1980;47:417-424.
28. Ravnik SE, Wolgemuth DJ. The developmentally restricted pattern of expression in the male germ line of a murine cyclin A, cyclin A2, suggests roles in both mitotic and meiotic cell cycles. Dev Biol. 1996;173:69-78.
29. Reis ED, Smyth S, Coller B. Mouse model of transluminal femoral artery injury. In: Simon DI, Rogers C, eds. Vascular Disease Injury: Preclinical Research. Totowa, NY: Humana Press, Inc.; 2000:107-109.
30. Reis ED, Roque M, Cordon-Cardo C, Drobnjak M, Fuster V, Badimon JJ. Apoptosis, proliferation, and p27 expression during vessel wall healing: time course study in a mouse model of transluminal femoral artery injury. J Vasc Surg. 2000;32:1022-1029.
31. Geary RL, Wong JM, Rossini A, Schwanz SM, Adams LD. Expression profiling identifies 147 genes contributing to a unique primate neointimal smooth muscle cell phenotype. Arterioscler Thromb Vasc Biol. 2002;22:2010-2016.
32. Gotwals PJ, Chi-Rosso G, Lindner V, Yang J, Ling L, Fawell SE, Koteliansky VE. The α1β1 integral is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization. J Clin Invest. 1996;97:2469-2477.
33. Rocnik EF, Chan BM, Pickering JG. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 1998;101:1889-1898.
34. Lemaitre V, O'Byrne TK, Borczuk AC, Okada Y, Tall AR, D'Armiento J. ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest. 2001;107:1227-1234.
35. Sala A, De Luca A, Giordano A, Peschle C. The retinoblastoma family member p107 binds to B-MYB and suppresses its autoregulatory activity. J Biol Chem. 1996:271:28738-28740.
36. Li X, McDonnell DP. The transcription factor B-Myb is maintained in an inhibited state in target cells through its interaction with the nuclear corepressors N-CoR and SMRT. Mol Cell Biol. 2002;22:3663-3673.
37. Cervellera MN, Sala A, Poly(ADP-ribose) polymerase is a B-MYB coactivator. J Biol Chem. 2000;275:10692-10696.
38. Baskar JF, Smith PP, Ciment GS, Hoffmann S, Tucker C, Tenney DJ, Colberg-Poley AM, Nelson JA, Ghazal P. Developmental analysis of the cytomegalovirus enhancer in transgenic animals. J Virol. 1996;70:3215-3226.